Grant Awards Cycle VI

Grant Awards in October 2001

Preface >>
Facts and Figures >>

Principal Investigator	Project Title/Link
Dr. William J. Burlingham University of Wisconsin Medical School, Madison, USA	Delayed Type Hypersensitivity (DTH) Status and MMF Monotherapy
Dr. Christiane Ferran Beth Israel Deaconess Medical Center, Boston, USA	Protective Effect of A20 against Transplant-Associated Vasculopathy
Prof. Edward K. Geissler University of Regensburg, Regensburg, Germany	Paclitaxel and Rapamycin: A One-Two Punch Against Rejection and Cancer in Organ Transplantation
Dr. David A. Gerber University of North Carolina, Chapel Hill, USA	The Immunologic Basis of Hepatic Progenitor Cell Transplantation
Prof. Michel Goldman Université Libre de Bruxelles, Bruxelles, Belgium	Dendritic Cells Transduced with the FasL Gene as a Tool to Regulate Allograft Immunity
Dr. Michael D. Gunn Duke University Medical Center, Durham, USA	The Role of Plasmacytoid Dendritic Cells in the Development of Tolerance
Dr. Anatolij Horuzsko Medical College of Georgia, Augusta, USA	Prevention of Skin Allograft Rejection by HLA-G-Modified Dendritic Cells
Prof. Ian Hutchinson University of Manchester, Manchester, UK	VEGF: A Central Mediator in both Acute and Chronic Transplant Rejection
Dr. Koichi Shimizu Brigham & Women's Hospital, Boston, USA	Source of Intimal Smooth Muscle like Cells in Aortic Allograft Arteriopathy
Dr. Thomas Wekerle Vienna General Hospital, Vienna, Austria	Tolerance through Hematopoietic Cell Transplantation with Costimulation Blockade